The estimated Net Worth of Stewart Mc Callum is at least $2.61 millier dollars as of 26 May 2016. Stewart Callum owns over 1,250 units of Recro Pharma Inc stock worth over $2,613 and over the last 9 years Stewart sold REPH stock worth over $0.
Stewart has made over 1 trades of the Recro Pharma Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Stewart bought 1,250 units of REPH stock worth $10,275 on 26 May 2016.
The largest trade Stewart's ever made was buying 1,250 units of Recro Pharma Inc stock on 26 May 2016 worth over $10,275. On average, Stewart trades about 179 units every 0 days since 2015. As of 26 May 2016 Stewart still owns at least 1,250 units of Recro Pharma Inc stock.
You can see the complete history of Stewart Callum stock trades at the bottom of the page.
Stewart's mailing address filed with the SEC is C/O RECRO PHARMA, INC., 490 LAPP ROAD, MALVERN, PA, 19355.
Over the last 11 years, insiders at Recro Pharma Inc have traded over $25,533,136 worth of Recro Pharma Inc stock and bought 3,055,820 units worth $22,429,197 . The most active insiders traders include Healthcare Master Fund Ltd ..., Investment Company, Inc. Awm et James E Deerfield Mgmt L.P..... On average, Recro Pharma Inc executives and independent directors trade stock every 31 days with the average trade being worth of $151,953. The most recent stock trade was executed by J David Jr Enloe on 15 March 2022, trading 512 units of REPH stock currently worth $1,004.
Recro Pharma Inc. is a contract development and manufacturing organization (CDMO) with capabilities from early feasibility to commercial manufacturing. With an expertise in solving complex manufacturing problems, Recro is a leading CDMO providing oral solid dosage form development, end-to-end regulatory support, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market.
Recro Pharma Inc executives and other stock owners filed with the SEC include: